• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ULTRAFLEX TRACHEOBRONCHIAL; PROSTHESIS, TRACHEAL, EXPANDABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ULTRAFLEX TRACHEOBRONCHIAL; PROSTHESIS, TRACHEAL, EXPANDABLE Back to Search Results
Model Number M00564840
Device Problem Activation Failure (3270)
Patient Problems Dyspnea (1816); Pneumothorax (2012); Heart Failure (2206)
Event Date 06/24/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental mdr will be filed.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2020 that an ultraflex tracheobronchial covered distal release stent was to be implanted above the main airway carina during a tracheal stent implantation procedure performed on (b)(6) 2020.Reportedly, the patient was in terrible condition prior to the scheduled procedure.According to the complainant, after the stent deployed, the physician checked the stent using the bronchoscope and noted the stent was slow to fully expand.Reportedly, a minute after stent implantation the patient sat up and experienced difficulty breathing leading to cardiac failure and a pneumothorax.The stent was removed using forceps and another ultraflex tracheobronchial stent was used to complete the procedure.The patient's condition at the conclusion of the procedure was reported to be stable but the physician also noted that the patient had pneumothorax.Reportedly, in the physician's assessment, the cardiac failure was caused by the stent failure to expand and the pneumothorax was caused by hyperventilation due to cardiac failure.Reportedly, the patient did not go into cardiac arrest and did not have a syncopal or vaso-vagal episode.Deploying the second stent was the only intervention reported to address the cardiac failure, difficulty breathing and pneumothorax.
 
Manufacturer Narrative
Block h6: problem code 3270 captures the reportable event of stent slow to fully expand.Patient code 2206 captures the reportable event of heart failure.Patient code 1816 captures the reportable event of dyspnea.Patient code 2012 captures the reportable event of pneumothorax.Block h10: an ultraflex tracheobronchial covered stent was received for analysis; the delivery system was not returned.The stent was received completely deployed.Visual examination of the returned device found the stent cover was torn.The loops of the stent were found bent.The outer diameter (od) of the stent was measured and was found to be within specification.No other issues were noted to the stent.The reported event of stent failure to expand was not confirmed.Taking all available information into consideration, the investigation concluded that the reported event and the observed failures were likely due to factors encountered during the procedure.It may be that how the device was handled or manipulated, the anatomy of the patient, the radial force of the stent and/or some issue with the retention suture during the procedure, limited the performance of the device and contributed to the stent failure to expand and the observed damage on the stent cover.Additionally, the loops of the stent were bent; however, there is not sufficient information about what could be the cause for this failure.Therefore, a review and analysis of all available information indicated the most probable cause is adverse event related to the procedure.A review of the device history record (dhr) was performed and confirmed that this device met all material, assembly, and performance specifications at the time of release for distribution.A labeling review was performed and, from the information available, there is no information that this device was used in a manner inconsistent with the directions for use (dfu) / product label.Additionally, pneumothorax and dyspnea are noted within the dfu as known potential adverse events associated with the use of this device.
 
Event Description
It was reported to boston scientific corporation on june 24, 2020 that an ultraflex tracheobronchial covered distal release stent was implanted above the main airway carina during a tracheal stent implantation procedure performed on (b)(6) 2020.Reportedly, the patient was in terrible condition prior to the scheduled procedure.According to the complainant, after the stent deployed, the physician checked the stent using the bronchoscope and noted the stent was slow to fully expand.Reportedly, a minute after stent implantation the patient sat up and experienced difficulty breathing leading to cardiac failure and a pneumothorax.The stent was removed using forceps and another ultraflex tracheobronchial stent was used to complete the procedure.The patient's condition at the conclusion of the procedure was reported to be stable but the physician also noted that the patient had pneumothorax.Reportedly, in the physician's assessment, the cardiac failure was caused by the stent failure to expand and the pneumothorax was caused by hyperventilation due to cardiac failure.Reportedly, the patient did not go into cardiac arrest and did not have a syncopal or vaso-vagal episode.Deploying the second stent was the only intervention reported to address the cardiac failure, difficulty breathing and pneumothorax.Additional information received on july 31, 2020.Reportedly, the reported heart/cardiac failure was not a pre-existing condition that the patient was diagnosed with prior to the procedure.
 
Manufacturer Narrative
Blocks b5 has been updated with the additional information received on (b)(6), 2020.Block h6: problem code 3270 captures the reportable event of stent slow to fully expand.Patient code 2206 captures the reportable event of heart failure.Patient code 1816 captures the reportable event of dyspnea.Patient code 2012 captures the reportable event of pneumothorax.Block h10: the device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental mdr will be filed.
 
Event Description
It was reported to boston scientific corporation on (b)(6), 2020 that an ultraflex tracheobronchial covered distal release stent was implanted above the main airway carina during a tracheal stent implantation procedure performed on (b)(6), 2020.Reportedly, the patient was in terrible condition prior to the scheduled procedure.According to the complainant, after the stent deployed, the physician checked the stent using the bronchoscope and noted the stent was slow to fully expand.Reportedly, a minute after stent implantation the patient sat up and experienced difficulty breathing leading to cardiac failure and a pneumothorax.The stent was removed using forceps and another ultraflex tracheobronchial stent was used to complete the procedure.The patient's condition at the conclusion of the procedure was reported to be stable but the physician also noted that the patient had pneumothorax.Reportedly, in the physician's assessment, the cardiac failure was caused by the stent failure to expand and the pneumothorax was caused by hyperventilation due to cardiac failure.Reportedly, the patient did not go into cardiac arrest and did not have a syncopal or vaso-vagal episode.Deploying the second stent was the only intervention reported to address the cardiac failure, difficulty breathing and pneumothorax.***additional information received on (b)(6), 2020*** reportedly, the reported heart/cardiac failure was not a pre-existing condition that the patient was diagnosed with prior to the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX TRACHEOBRONCHIAL
Type of Device
PROSTHESIS, TRACHEAL, EXPANDABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key10270255
MDR Text Key198700144
Report Number3005099803-2020-02750
Device Sequence Number1
Product Code JCT
Combination Product (y/n)N
PMA/PMN Number
K012883
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup,Followup
Report Date 09/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/01/2020
Device Model NumberM00564840
Device Catalogue Number6484
Device Lot Number0022734118
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/26/2020
Initial Date Manufacturer Received 06/24/2020
Initial Date FDA Received07/14/2020
Supplement Dates Manufacturer Received07/31/2020
09/01/2020
Supplement Dates FDA Received08/21/2020
09/22/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
Patient Weight65
-
-